Retraction Note: Vitamin D supplementation during pregnancy inhibits the activation of fetal membrane NF-κB pathway
- PMID: 36459002
- DOI: 10.26355/eurrev_202211_30349
Retraction Note: Vitamin D supplementation during pregnancy inhibits the activation of fetal membrane NF-κB pathway
Abstract
The article "Vitamin D supplementation during pregnancy inhibits the activation of fetal membrane NF-κB pathway, by N. Gurkan, published in Eur Rev Med Pharmacol Sci 2022; 26 (16): 5926-5931-10.26355/eurrev_202208_29532-PMID: 36066168" has been retracted by the author as she stated that Vitamin D was used in the study as supplement and not a drug without the permission of the Ministry. Although Vitamin D is a commonly used supplement during pregnancy, the Local Ethics Committee accepted it as a drug and asked for it to be approved by the Ministry of Health. Therefore, the manuscript has been withdrawn. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/29532.
Retraction of
-
Vitamin D supplementation during pregnancy inhibits the activation of fetal membrane NF-κB pathway.Eur Rev Med Pharmacol Sci. 2022 Aug;26(16):5926-5931. doi: 10.26355/eurrev_202208_29532. Eur Rev Med Pharmacol Sci. 2022. Retraction in: Eur Rev Med Pharmacol Sci. 2022 Nov;26(22):8205. doi: 10.26355/eurrev_202211_30349. PMID: 36066168 Retracted. Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources
